Neurology Journal
Fecha de publicación: 30 de octubre de 2020
DOI: https://doi.org/10.1007/s00415-020-10108-x
Autores: Antoine Guilmot, Sofia Maldonado Slootjes, Amina Sellimi, Maroussia Bronchain, Bernard Hanseeuw, Leila Belkhir, Jean Cyr Yombi, Julien De Greef, Lucie Pothen, Halil Yildiz, Thierry Duprez, Catherine Fillée, Ahalieyah Anantharajah, Antoine Capes, Philippe Hantson, Philippe Jacquerye, Jean-Marc Raymackers, Frederic London, Souraya El Sankari, Adrian Ivanoiu, Pietro Maggi & Vincent van Pesch
Background: Evidence of immune-mediated neurological syndromes associated with the severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection is limited. We therefore investigated clinical, serological and CSF features of coronavirus disease 2019 (COVID-19) patients with neurological manifestations.
